This observational study examined the impact of testosterone replacement therapy (TRT) on hemoglobin levels in 39 male blood donors, revealing that 25% of clinic visits recorded hemoglobin levels ≥180 g/L, and 44% of repeat donors had persistently elevated levels. This suggests that blood donation alone may be insufficient to manage
